5255 — Monstarlab Holdings Income Statement
0.000.00%
Last trade - 00:00- ¥9bn
- ¥15bn
- ¥13bn
Annual income statement for Monstarlab Holdings, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Yuho |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 7,420 | 9,346 | 14,271 | 13,347 |
| Cost of Revenue | ||||
| Gross Profit | 2,148 | 2,928 | 4,945 | 3,340 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 8,882 | 12,489 | 14,589 | 15,404 |
| Operating Profit | -1,463 | -3,143 | -318 | -2,057 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -1,549 | -3,090 | -447 | -2,156 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -1,473 | -3,089 | -724 | -2,320 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -1,274 | -3,053 | -675 | -2,355 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -1,274 | -3,053 | -675 | -2,355 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -25.4 | -46.3 | -16.8 | -85.5 |
| Dividends per Share |